#1 Clinical Trials Search in Europe

Taxanes

Taxanes are a class of chemotherapy drugs commonly used in the treatment of various cancers, particularly breast cancer. This article explores recent clinical trials investigating the use of taxanes, either alone or in combination with other drugs, to improve outcomes for cancer patients. We’ll look at how researchers are testing different dosing strategies, combinations, and applications of taxanes to enhance their effectiveness while managing side effects.

Table of Contents

What are Taxanes?

Taxanes are a class of chemotherapy drugs widely used in cancer treatment. The two most common taxanes are paclitaxel (also known as Taxol) and docetaxel (also known as Taxotere)[1]. These medications are derived from plants and work by interfering with cell division, making them effective against rapidly dividing cancer cells.

Conditions Treated with Taxanes

Taxanes are used to treat various types of cancer, including:

  • Breast cancer: Taxanes are commonly used in both early-stage and advanced breast cancer treatment[2][3]
  • HER2-positive breast cancer: Taxanes are often combined with other targeted therapies for this specific type of breast cancer[4]
  • Gastric cancer: Taxanes may be used in combination with other drugs for advanced gastric (stomach) cancer[5]

How Taxanes Work

Taxanes work by disrupting the normal function of microtubules, which are essential structures in cell division. By interfering with this process, taxanes can stop cancer cells from multiplying and spreading[6]. This mechanism of action makes taxanes effective against many types of cancer, especially those characterized by rapidly dividing cells.

How Taxanes are Administered

Taxanes are typically given intravenously (through a vein) in a hospital or clinic setting. The dosage and frequency can vary depending on the specific treatment plan and type of cancer. Some common administration methods include:

  • Weekly doses: For example, paclitaxel may be given at 80 mg/m² weekly[6]
  • Every three weeks: Docetaxel might be administered at 75-100 mg/m² every three weeks[6]
  • In combination with other drugs: Taxanes are often given alongside other chemotherapy or targeted therapy medications[4]

Side Effects of Taxanes

Like all chemotherapy drugs, taxanes can cause side effects. Some common side effects include:

  • Anemia: A decrease in red blood cells, which can cause fatigue[7]
  • Peripheral neuropathy: Numbness, tingling, or pain in the hands and feet[7]
  • Neutropenia: A decrease in white blood cells, which can increase the risk of infections[2]
  • Hypersensitivity reactions: Allergic-type reactions that can occur during or shortly after infusion[1]

Your healthcare team will monitor you closely for these side effects and may adjust your treatment plan if necessary.

Taxanes in Combination Therapies

Taxanes are often used in combination with other cancer treatments to enhance their effectiveness. Some common combinations include:

  • Taxanes with trastuzumab (Herceptin) and pertuzumab (Perjeta) for HER2-positive breast cancer[4]
  • Taxanes with bevacizumab (Avastin) for metastatic breast cancer[6]
  • Taxanes with carboplatin for triple-negative breast cancer[2]

Ongoing Research with Taxanes

Researchers continue to study taxanes to improve their effectiveness and reduce side effects. Some areas of ongoing research include:

  • Combining taxanes with new targeted therapies, such as tyrosine kinase inhibitors, for better outcomes in certain types of cancer[4]
  • Investigating ways to reduce side effects, such as using supplements like Epidiferphane alongside taxane treatment[7]
  • Exploring the use of taxanes in neoadjuvant therapy (treatment given before surgery) for breast cancer[8]

As research continues, new applications and improved treatment protocols for taxanes may be developed, potentially leading to better outcomes for cancer patients.

Aspect Details
Main focus Investigating taxanes in various cancer treatments, particularly breast cancer
Key combinations Taxanes with targeted therapies (e.g., trastuzumab, bevacizumab), other chemotherapy drugs
Treatment settings Neoadjuvant (before surgery), adjuvant (after surgery), metastatic disease
Primary outcomes Progression-free survival, pathological complete response, overall survival
Safety considerations Managing side effects, testing dose strategies, evaluating hypersensitivity reactions
Emerging strategies Test dose programs, combination with novel drugs, personalized dosing approaches

FAQ

  • What are taxanes? Taxanes are a class of chemotherapy drugs that include paclitaxel and docetaxel. They work by interfering with cell division, making them effective against rapidly dividing cancer cells.
  • How are taxanes typically used in cancer treatment? Taxanes are commonly used to treat various types of cancer, especially breast cancer. They can be given alone or in combination with other drugs, and are often part of standard chemotherapy regimens.
  • What are some common side effects of taxanes? Common side effects of taxanes include hair loss, nausea, fatigue, and peripheral neuropathy (nerve damage that can cause numbness or tingling in hands and feet). Some patients may also experience allergic reactions.
  • Why are researchers studying new ways to use taxanes? Researchers are exploring new ways to use taxanes to improve their effectiveness, reduce side effects, and overcome drug resistance. This includes testing different dosing schedules, combining taxanes with targeted therapies, and using them in earlier stages of treatment.
  • What is a 'test dose' program for taxanes? A test dose program involves giving a small amount of the taxane drug before administering the full dose. This is being studied as a way to potentially reduce the risk and severity of hypersensitivity reactions in some patients.

Ongoing Clinical Trials on Taxanes

  • Study on Aconite Pain Oil to Prevent and Reduce Symptoms of Chemotherapy-Induced Polyneuropathy in Cancer Patients

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany

Glossary

  • Taxanes: A class of chemotherapy drugs that includes paclitaxel and docetaxel, used to treat various types of cancer by interfering with cell division.
  • Neoadjuvant chemotherapy: Chemotherapy given before surgery to shrink tumors and potentially improve surgical outcomes.
  • HER2-positive breast cancer: A type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), which promotes cancer cell growth.
  • Progression-free survival (PFS): The length of time during and after treatment that a patient lives with cancer without it worsening.
  • Pathological Complete Response (pCR): The absence of all signs of cancer in tissue samples removed during surgery or biopsy after treatment.
  • Hypersensitivity reaction: An exaggerated or inappropriate immune response to a substance, which can be severe or life-threatening in some cases.
  • Peripheral neuropathy: Nerve damage that can cause numbness, tingling, pain, or weakness, usually in the hands and feet.
  • Relative dose intensity (RDI): A measure of the amount of chemotherapy delivered over time compared to the standard dose, which can be affected by dose reductions or delays.

References

  1. https://clinicaltrials.gov/study/NCT00277043
  2. https://clinicaltrials.gov/study/NCT02455141
  3. https://clinicaltrials.gov/study/NCT06217185
  4. https://clinicaltrials.gov/study/NCT04760431
  5. https://clinicaltrials.gov/study/NCT04920747
  6. https://clinicaltrials.gov/study/NCT01200212
  7. https://clinicaltrials.gov/study/NCT05074290
  8. https://clinicaltrials.gov/study/NCT04290793